Simplex Trading
OMED

Simplex Trading’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Simplex Trading’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-60
Closed -$13K – 8657
2018
Q2 		$13K Sell
60
-63
-51% -$183 ﹤0.01% 6201
2018
Q1 		$2K Buy
123
+31
+34% +$85 ﹤0.01% 5501
2017
Q4 		$3K Buy
+92
New +$400 ﹤0.01% 5090
2017
Q3 		– Sell
-34
Closed -$1K – 7311
2017
Q2 		$1K Buy
34
+19
+127% +$79 ﹤0.01% 5951
2017
Q1 		$2K Sell
15
-65
-81% -$571 ﹤0.01% 5494
2016
Q4 		$3K Buy
80
+58
+264% +$533 ﹤0.01% 4947
2016
Q3 		$1K Sell
22
-36
-62% -$419 ﹤0.01% 5672
2016
Q2 		$7K Buy
58
+43
+287% +$522 ﹤0.01% 4017
2016
Q1 		$2K Sell
15
-3
-17% -$35 ﹤0.01% 4968
2015
Q4 		$7K Buy
+18
New +$369 ﹤0.01% 3691
2015
Q2 		– Sell
-195
Closed -$83K – 6560
2015
Q1 		$83K Buy
195
+145
+290% +$3.68K 0.01% 1213
2014
Q4 		$15K Buy
+50
New +$1.02K ﹤0.01% 2300

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's OMED Position: Q1 2019 in Review

Simplex Trading sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2019, closing a stake of 15 shares.

Simplex Trading first reported a position in OMED in Q2 2015 and held it in 14 quarters. The position peaked at $344K in Q1 2017. 41 funds tracked by Wall St. Rank hold OMED as of Q1 2019.

  • Simplex Trading reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 15 OncoMed Pharmaceuticals, Inc. shares in Q1 2019.
  • Simplex Trading first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2015 and held it in 14 quarters.
  • Simplex Trading's OncoMed Pharmaceuticals, Inc. position peaked at $344K in Q1 2017.
  • 41 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.